To further understand how LCAT promotes the progression of ACC and COAD tumors and how it inhibits the progression of LGG and LIHC tumors, we divided ACC, COAD, LGG, and LIHC into two groups based on LCAT expression and performed functional enrichment analysis on the differential genes between the two groups. The gene discussed is LCAT; the disease is adrenal cortex carcinoma.